Clinical Trial Update: Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

View source ↗

Summary

This update reports on a completed clinical trial evaluating pulmonary function in Hodgkin lymphoma patients treated with bleomycin-based chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hodgkin's Disease | Status: COMPLETED